1-allyl ergot alkaloid derivatives, method for producing the same and the use thereof for preventing and treating migraine
Details for Australian Patent Application No. 2002363847 (hide)
International Classifications
Event Publications
17 July 2003 Complete Application Filed
Priority application(s): 102 12 564.3 12.03.02 DE
30 October 2003 Application Open to Public Inspection
Published as AU-B-2002363847
11 January 2007 Amendment Made
The nature of the amendment is: Amend co-inventor name from Jahnichen, Sven to Jaehnichen, Sven 2003
21 June 2007 Change of Name(s) of Applicant(s), Section 104
Neurobiotec GmbH The name of the applicant has been changed to Axxonis Pharma AG 2003
27 November 2008 Application Accepted
Published as AU-B-2002363847
26 March 2009 Standard Patent Sealed
15 July 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired
This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2002363846-LOW-PRESSURE CIRCUIT FOR A RESERVOIR INJECTION SYSTEM
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser